122 related articles for article (PubMed ID: 25779658)
1. Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.
Fonville NC; Vaksman Z; McIver LJ; Garner HR
Oncotarget; 2015 May; 6(13):11407-20. PubMed ID: 25779658
[TBL] [Abstract][Full Text] [Related]
2. High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
Velmurugan KR; Varghese RT; Fonville NC; Garner HR
Oncogene; 2017 Nov; 36(46):6383-6390. PubMed ID: 28759038
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite genotyping reveals a signature in breast cancer exomes.
McIver LJ; Fonville NC; Karunasena E; Garner HR
Breast Cancer Res Treat; 2014 Jun; 145(3):791-8. PubMed ID: 24838940
[TBL] [Abstract][Full Text] [Related]
4. Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer.
Zhang B; Nie X; Miao X; Wang S; Li J; Wang S
J Cell Mol Med; 2021 Mar; 25(6):2918-2930. PubMed ID: 33543590
[TBL] [Abstract][Full Text] [Related]
5. Germline microsatellite genotypes differentiate children with medulloblastoma.
Rivero-Hinojosa S; Kinney N; Garner HR; Rood BR
Neuro Oncol; 2020 Jan; 22(1):152-162. PubMed ID: 31562520
[TBL] [Abstract][Full Text] [Related]
6. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.
Sun T; Bi F; Liu Z; Yang Q
Aging (Albany NY); 2020 Jul; 12(13):13281-13296. PubMed ID: 32647070
[TBL] [Abstract][Full Text] [Related]
7. Analysis of susceptible genes and chromosome loci for lung cancers by automated gene prediction tools and genome scanning meta-analysis.
Tian Y; Wang D
Int J Clin Exp Pathol; 2015; 8(9):11929-33. PubMed ID: 26617950
[TBL] [Abstract][Full Text] [Related]
8. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
10. Genomic Biomarkers for Breast Cancer Risk.
Walsh MF; Nathanson KL; Couch FJ; Offit K
Adv Exp Med Biol; 2016; 882():1-32. PubMed ID: 26987529
[TBL] [Abstract][Full Text] [Related]
11. Verifying the markers of ovarian cancer using RNA-seq data.
Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
[TBL] [Abstract][Full Text] [Related]
12. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
[TBL] [Abstract][Full Text] [Related]
13. Phylostratigraphic analysis of gene co-expression network reveals the evolution of functional modules for ovarian cancer.
Zhang L; Tan Y; Fan S; Zhang X; Zhang Z
Sci Rep; 2019 Feb; 9(1):2623. PubMed ID: 30796309
[TBL] [Abstract][Full Text] [Related]
14. Reclassifying colorectal cancer subtypes.
Burki TK
Lancet Oncol; 2015 Dec; 16(16):e591. PubMed ID: 26511645
[No Abstract] [Full Text] [Related]
15. Conservation genomics of anadromous Atlantic salmon across its North American range: outlier loci identify the same patterns of population structure as neutral loci.
Moore JS; Bourret V; Dionne M; Bradbury I; O'Reilly P; Kent M; Chaput G; Bernatchez L
Mol Ecol; 2014 Dec; 23(23):5680-97. PubMed ID: 25327895
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling and commercial predication assays in ovarian cancer: still not ready for prime time?
Kohn EC
Am Soc Clin Oncol Educ Book; 2014; ():139-47. PubMed ID: 24857070
[TBL] [Abstract][Full Text] [Related]
17. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
[TBL] [Abstract][Full Text] [Related]
18. Population-scale analysis of human microsatellites reveals novel sources of exonic variation.
McIver LJ; McCormick JF; Martin A; Fondon JW; Garner HR
Gene; 2013 Mar; 516(2):328-34. PubMed ID: 23274653
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer.
Codegoni AM; Bertoni F; Colella G; Caspani G; Grassi L; D'Incalci M; Broggini M
Oncol Res; 1999; 11(7):297-301. PubMed ID: 10757443
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Yan S; Fang J; Chen Y; Xie Y; Zhang S; Zhu X; Fang F
BMC Cancer; 2020 Dec; 20(1):1205. PubMed ID: 33287740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
